Guides

Practical answers for quality teams

Short, specific guides to the questions we hear most from quality and manufacturing teams in regulated industries.

Which AI tools automate GMP batch record review and release?

The three types of AI tool used in GMP batch record review, what each one automates, and which parts of batch release must stay with QA and the Qualified Person.

Savi C., Co-Founder

Which AI software automates pharmaceutical deviation investigations and root cause analysis?

What 21 CFR 211.192 expects from a deviation investigation, which steps AI can automate and which it cannot, and how to compare AI investigation software.

Savi C., Co-Founder

How should quality leaders compare AI manufacturing software for batch review automation?

A buyer's framework for comparing AI batch review software in regulated manufacturing: the criteria that matter, tests to run in a demo, and red flags to walk away from.

Savi C., Co-Founder

What AI manufacturing software best supports ISO 22716-compliant cosmetics plants?

No software is ISO 22716 certified, because the standard applies to your plant. Here is which type of tool holds the evidence for each ISO 22716 clause, and where AI review helps.

Savi C., Co-Founder

What AI manufacturing software should midsize cosmetics manufacturers compare for audit readiness?

What FDA, retailers and ISO 22716 auditors actually pull at a cosmetics plant, which types of software make those requests fast, and what a midsize plant with a small QA team should compare.

Savi C., Co-Founder

Which AI manufacturing software supports end-to-end GxP operations in cosmetics?

End-to-end GxP in cosmetics usually means a stack: ERP or MES, a QMS, formulation and regulatory software, and a review layer. Here is which tool type covers which operation, and where AI fits.

Savi C., Co-Founder

How do you select AI manufacturing software for supplier quality oversight?

What supplier quality oversight involves in cosmetics, drug, supplement and food plants, where AI helps, and a checklist for comparing software before you buy.

Savi C., Co-Founder

How do you choose AI manufacturing software for raw-material certificate management?

What raw-material certificate management needs to cover, from CoAs and specifications to supplier history and identity testing, and how to compare AI software for it.

Savi C., Co-Founder

Which AI manufacturing software should quality managers shortlist for regulatory recordkeeping?

Which records cosmetics, drug, supplement and food manufacturers must keep and for how long, and how AI software that finds and checks records differs from a document management system.

Savi C., Co-Founder

Which AI software should cosmetics manufacturers choose for MoCRA compliance?

MoCRA covers registration, listing, safety substantiation, adverse events and manufacturing records. No single tool does all of it. Here is which type of software covers which requirement, and where AI helps.

Savi C., Co-Founder

Which AI software works for regulated cosmetics deviation investigations?

What a cosmetics deviation investigation needs under ISO 22716 and MoCRA, what AI can and cannot do in one, and how to compare QMS assistants with an AI review layer.

Savi C., Co-Founder

What AI manufacturing software fits cosmetics plants needing on-premise deployment?

Why some cosmetics plants need on-premise or air-gapped AI, which quality and compliance tools offer it, and what to check before you buy.

Savi C., Co-Founder

AI batch record review vs manual review

How AI-assisted batch record review compares with manual QA review on speed, consistency, trending and accountability, and where people still have to decide.

Savi C., Co-Founder

What is review by exception for batch records?

How review by exception works for GMP batch records, what counts as an exception, what regulators expect, and how it can work on paper records as well as electronic ones.

Savi C., Co-Founder

Batch record review checklist for GMP pharmaceutical manufacturing

A practical GMP batch record review checklist built on 21 CFR 211.188 and 211.192 and EU GMP Chapter 4: master record, materials, process steps, documentation practice, deviations and release.

Savi C., Co-Founder

DHR review checklist under the FDA QMSR

What a device history record review needs to cover now that the QMSR incorporates ISO 13485, with a practical checklist for travelers, labeling, nonconformances and release.

Savi C., Co-Founder

Can AI be used for GMP batch record review? What regulators expect

What FDA and EU rules say about using AI to review GMP batch records: the rules that already apply, the January 2026 EMA and FDA principles, draft Annex 22, and what to ask a vendor.

Savi C., Co-Founder

What changed for DHRs, DMRs and DHFs under the QMSR

How the FDA QMSR changed device records: what replaced the DMR, DHR and DHF, what FDA can now inspect, and what to update in your quality system.

Savi C., Co-Founder

How do you automate batch record review when records are on paper?

A practical route to automating review of paper GMP batch records without an EBR project: scanning, reading handwriting, checking against the master record, validation and true copies.

Savi C., Co-Founder

What are the most common batch record errors found in review?

The batch record errors QA reviewers find most often, from missing signatures and blank fields to GDP corrections, calculation errors and unreferenced deviations, and how to prevent them.

Savi C., Co-Founder

How do you validate an AI tool in a GxP environment?

A practical approach to validating an AI tool used in GxP work: intended use, risk, GAMP 5 and its AI guidance, EU Annex 11, FDA computer software assurance, and control after go-live.

Savi C., Co-Founder

Will AI-assisted batch record review hold up in an FDA inspection?

What an FDA investigator is likely to ask about AI-assisted batch record review, which regulations apply, and the evidence to have ready so the review is defensible.

Savi C., Co-Founder

AI record review vs an EBR or MES: do you need both?

How AI record review differs from an electronic batch record or MES, what each one does well, and when a site needs one, the other, or both.

Savi C., Co-Founder

How do you speed up deviation investigations without weakening them?

Where deviation investigations lose time, what regulators require them to contain, and practical ways to close them faster without cutting root cause analysis or impact assessment.

Savi C., Co-Founder

How do you check CAPA effectiveness?

How to plan and perform a CAPA effectiveness check: what to measure, when, what counts as success, and what ICH Q10, EU GMP and ISO 13485 expect.

Savi C., Co-Founder

What should audit trail review cover, and how often should it happen?

What a GMP audit trail review should look at, how often FDA, EU Annex 11, PIC/S and MHRA expect it, and how to split batch-level review from periodic system review.

Savi C., Co-Founder

What does 21 CFR Part 11 require for electronic signatures in batch record review?

The 21 CFR Part 11 signature rules that matter when batch records are reviewed and released electronically: manifestation, record linking, uniqueness, signature components and password controls.

Savi C., Co-Founder

How do you make certified true copies of paper batch records?

How to make and control a true copy of a paper GMP batch record: what FDA, PIC/S and MHRA expect, the copy and verification steps, and when the paper original can be retired.

Savi C., Co-Founder

What does the 2022 EU GMP Annex 1 change for sterile batch records and review?

What the revised EU GMP Annex 1 asks to be recorded in sterile batch records and reviewed before certification or release, and how the contamination control strategy frames that review.

Savi C., Co-Founder

How do you improve right-first-time batch records?

How to raise the share of batch records that pass QA review with no query or correction: measuring it honestly, designing the record, targeted GDP training, upstream checks and trending findings.

Savi C., Co-Founder

What does 21 CFR 820.45 require for device labeling and packaging inspection?

What 21 CFR 820.45 requires under the QMSR: documented labeling and packaging procedures, the five accuracy checks before release, documented labeling release, and mix-up prevention.

Savi C., Co-Founder

Where does the UDI need to appear in device records?

Where FDA requires the unique device identifier beyond the label: production records, complaint and servicing records, MDR and correction reports, labeling inspection and the GUDID.

Savi C., Co-Founder

How should nonconforming product and MRB dispositions be handled under ISO 13485 clause 8.3?

How to run nonconforming product control and MRB dispositions under ISO 13485 clause 8.3 and the QMSR: concessions, rework re-verification, after-delivery actions and the records each needs.

Savi C., Co-Founder

What do complaint files need under the QMSR?

What a medical device complaint file must contain under the QMSR: ISO 13485 clause 8.2.2 procedures, the seven items 21 CFR 820.35(a) requires, and the Part 803 MDR decision and records.

Savi C., Co-Founder

What supplier controls does ISO 13485 require for device manufacturers?

What ISO 13485 clause 7.4 requires of medical device manufacturers under the QMSR: supplier criteria, monitoring and re-evaluation, purchasing information, change notification and verification.

Savi C., Co-Founder

How should sponsors review contract manufacturer batch records?

What FDA and EU GMP expect from a product owner reviewing batch records made at a contract manufacturer, what the quality agreement should settle, and a checklist for each record.

Savi C., Co-Founder

How do you respond to FDA 483 observations about batch records and documentation?

How to respond to Form FDA 483 observations on batch records and documentation practice: the 15 business day window, what a credible response contains, and how to fix the system, not the page.

Savi C., Co-Founder

What records does FSMA 204 require, and how do production records feed them?

What the FDA food traceability rule requires for foods on the Food Traceability List, which key data elements come from production records, and what to check before FDA asks.

Savi C., Co-Founder

Which metrics show whether batch record review is working?

Five metrics that show whether batch record review is catching problems and moving at a sustainable pace, how to define each one, and how they fit ICH Q10 management review.

Savi C., Co-Founder

How should chain of identity and chain of custody be checked in cell and gene therapy batch records?

How to check chain of identity and chain of custody in cell therapy batch records, from collection to final label, based on FDA’s CAR T guidance and common industry practice.

Savi C., Co-Founder

How should equipment use and cleaning logbooks be reviewed?

What 21 CFR 211.182 and EU GMP Chapter 4 require in equipment use and cleaning logs, and how to review a logbook on its own and against the batch records that cite it.

Savi C., Co-Founder

What should line clearance records show, and how are they reviewed?

What 21 CFR 211.130(e) and EU GMP Chapters 4 and 5 require of line clearance, what a clearance record should show, and how QA reviews it as part of the packaging record.

Savi C., Co-Founder

How do you review cleaning records and keep them consistent with cleaning validation?

How to review routine equipment cleaning records under 21 CFR 211.67 and 211.182, and how to check that each cleaning matches what EU GMP Annex 15 cleaning validation actually proved.

Savi C., Co-Founder

How should environmental monitoring data be reviewed and trended?

How to review environmental monitoring results for batch release and trend them over time, based on EU GMP Annex 1 (2022) section 9 and FDA’s 2004 aseptic processing guidance.

Savi C., Co-Founder

How do you check yield and reconciliation in batch records?

How to check yield calculations and labeling reconciliation in a batch record under 21 CFR 211.103, 211.125 and 211.188 and EU GMP Chapters 4 and 5, and when a result has to be investigated.

Savi C., Co-Founder

How long should batch record review take, and how do you shorten it?

What actually drives the time it takes to review a GMP batch record, why the queue is usually longer than the review itself, and practical ways to shorten it without weakening QA approval.

Savi C., Co-Founder

Good documentation practice: how should corrections be made in batch records?

How to correct an entry in a GMP batch record under good documentation practice: single line, original still readable, initials, date and reason, plus what reviewers check and common mistakes.

Savi C., Co-Founder

What does ALCOA+ mean for batch records?

What each ALCOA+ attribute means for a paper or electronic batch record, what FDA, MHRA and PIC/S guidance expect, and the record-level checks a reviewer can apply.

Savi C., Co-Founder

What does 21 CFR 211.192 require? Production record review and investigations explained

A sentence-by-sentence reading of 21 CFR 211.192: what the quality unit must review before release, what triggers an investigation, how far it must reach, and what the record must contain.

Savi C., Co-Founder

What does a Qualified Person check before certifying a batch under EU GMP Annex 16?

What EU GMP Annex 16 asks a Qualified Person to confirm before certifying a batch: the duties they must perform personally, the 1.7 checks, deviations, imports and record keeping.

Savi C., Co-Founder

What is the difference between a deviation, an OOS and an OOT result?

Deviation, OOS and OOT explained: how each is defined, what triggers it, how FDA expects OOS results to be investigated, and why out-of-trend results still need attention.

Savi C., Co-Founder

How do you prepare an APQR or PQR faster?

What the FDA annual product review under 21 CFR 211.180(e) and the EU product quality review under GMP Chapter 1 require, and practical ways to cut the time it takes to prepare them.

Savi C., Co-Founder

How should incoming CoAs be reviewed under 21 CFR 211.84?

What 21 CFR 211.84 requires before a supplier certificate of analysis can stand in for your own testing, and a practical checklist for reviewing each incoming CoA.

Savi C., Co-Founder

What does 21 CFR Part 111 require in a dietary supplement batch record review?

What a dietary supplement batch production record must contain under 21 CFR 111.260, what quality control must review and decide under 111.123, and a checklist for the review.

Savi C., Co-Founder

How should HACCP and CCP monitoring records be reviewed under FSMA?

What 21 CFR Part 117 requires when reviewing CCP monitoring and corrective action records, including the 7 working day timeframe, who must review, and what the review must confirm.

Savi C., Co-Founder

What should a cosmetics batch record review cover under ISO 22716?

What a cosmetics batch record review should check under ISO 22716 GMP, from raw material lots and process parameters to deviations and release, and where MoCRA GMP stands.

Savi C., Co-Founder

How should contract manufacturers handle DHR review across multiple device customers?

How a medical device contract manufacturer can run DHR review for many customers under the QMSR: quality agreements, per-customer requirements, release responsibilities and records.

Savi C., Co-Founder